| Description | IL11 Human Pre-designed siRNA Set A contains three designed siRNAs for IL11 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control. Components IL11 siRNA-1: 5 nmol (HPLC) IL11 siRNA-2: 5 nmol (HPLC) IL11 siRNA-3: 5 nmol (HPLC) siRNA Negative Control: 5 IL11 Human Pre-designed siRNA Set A contains three designed siRNAs for IL11 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control. Components IL11 siRNA-1: 5 nmol (HPLC) IL11 siRNA-2: 5 nmol (HPLC) IL11 siRNA-3: 5 nmol (HPLC) siRNA Negative Control: 5 nmol (HPLC) FAM-labeled siRNA Negative Control: 5 nmol (HPLC) GAPDH siRNA Positive Control:5 nmol (HPLC)... Read More | Biochemical Test:SDS-PAGE (purity > 80%); Western blot with patient sample.Calculated Isoelectric Point:pH 6.47 | Usually used industrially for the resolution of chiral compounds and the transesterification production of biodiesel | Store at +4°C. Store under desiccating conditions. The product can be stored for up to 12 months | Purity: >90%, by SDS-PAGE visualized with Coomassie® Blue Staining. Description: Major histocompatibility complex, class II, DR alpha (HLA-DRA) belongs to the MHC class II family. HLA-DRA binds peptides derived from antigens which access the endocytic route of antigen presenting cells (APC) Purity: >90%, by SDS-PAGE visualized with Coomassie® Blue Staining. Description: Major histocompatibility complex, class II, DR alpha (HLA-DRA) belongs to the MHC class II family. HLA-DRA binds peptides derived from antigens which access the endocytic route of antigen presenting cells (APC) and presents them on the cell surface for identification by the CD4 T-cells. The peptide binding cleft accommodates peptides of 10-30 residues. The peptides presented by MHC class II molecules are generated mainly by degradation of proteins which access the endocytic route, where they are processed by lysosomal proteases and other hydrolases... Read More |